Lv4
440 积分 2025-08-27 加入
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
1天前
待确认
Anlotinib: First Global Approval
4天前
已完结
Bcr-Abl Kinase Domain Mutations in Imatinib and in Second-Generation Tyrosine Kinase Inhibitor Eras: Seven Years of Mutation Analysis, a Report by the GIMEMA CML Working Party
7天前
已关闭
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer
8天前
已关闭
Primary cells in BCR/FGFR1‐positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib
12天前
已完结
Myeloproliferative disorder associated with 8p11 translocations [letter; comment]
12天前
已关闭
Increasing incidence of endometrial cancer demands global action
14天前
已关闭
Targeting molecular pathways in endometrial cancer: A focus on the FGFR pathway
16天前
已完结
Olverembatinib (HQP1351) Enhances Antitumor Effects of Chemotherapy in Philadelphia Chromosome-Positive (Ph⁺) Acute Lymphoblastic Leukemia (ALL)
21天前
已关闭
Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes
1个月前
已完结
皖公网安备34019202002308
